Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not"

BACKGROUND: Imatinib is a tyrosine-kinase inhibitor; for which there is limited information regarding its effects on AIDS Kaposi's sarcoma and none in patients with transplant-associated Kaposi's sarcoma. Sirolimus, an immunosuppressive drug used for kidney transplant, exhibits antiangioge...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkow, Patricia, Zinser, Juan W, Correa-Rotter, Ricardo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852096/
https://www.ncbi.nlm.nih.gov/pubmed/17386117
http://dx.doi.org/10.1186/1471-2369-8-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852096/
https://www.ncbi.nlm.nih.gov/pubmed/17386117
http://dx.doi.org/10.1186/1471-2369-8-6

Ejemplares similares